Auto injector
Latest F. Hoffmann-La Roche AG Patents:
- METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
- GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
- Compounds for treating spinal muscular atrophy
- Prefilled syringe and method of preparing a prefilled syringe
- METHODS OF USING A BISPECIFIC ANTIBODY THAT RECOGNIZES COAGULATION FACTOR IX AND/OR ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X AND/OR ACTIVATED COAGULATION FACTOR X
Description
Fig.
Fig.
Fig.
Fig.
Fig.
Fig.
Fig.
The dashed lines show the medication and mechanism for injection of the medication seen through the transparent or translucent main body and form no part of the claim.
Claims
The ornamental design for an auto injector, as shown and described.
Referenced Cited
U.S. Patent Documents
D492405 | June 29, 2004 | Bainton |
D612486 | March 23, 2010 | Van der Stappen |
D619244 | July 6, 2010 | Van der Stappen |
D620106 | July 20, 2010 | Van der Stappen |
D621929 | August 17, 2010 | Van der Stappen |
D627061 | November 9, 2010 | Van der Stappen |
D648024 | November 1, 2011 | Harkin |
D696774 | December 31, 2013 | Guarraia |
D696775 | December 31, 2013 | Guarraia |
D708317 | July 1, 2014 | Schneider |
D758567 | June 7, 2016 | Wohlfahrt |
D758569 | June 7, 2016 | Wohlfahrt |
Patent History
Patent number: D903109
Type: Grant
Filed: Oct 5, 2017
Date of Patent: Nov 24, 2020
Assignee: F. Hoffmann-La Roche AG (Basel)
Inventor: Florian Wildenhahn (Rheinfelden)
Primary Examiner: Eliza Z Bennett-Hattan
Application Number: 35/505,321
Type: Grant
Filed: Oct 5, 2017
Date of Patent: Nov 24, 2020
Assignee: F. Hoffmann-La Roche AG (Basel)
Inventor: Florian Wildenhahn (Rheinfelden)
Primary Examiner: Eliza Z Bennett-Hattan
Application Number: 35/505,321
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)